España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nuvalent
NUVL
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$73.52
0.65
0.89%
Last update: 10:13 AM
15 minutes delayed
Get Report
Watch
Nuvalent (NUVL) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Nuvalent (NASDAQ:NUVL) Stock
Nuvalent Stock (NASDAQ: NUVL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, June 09, 2024
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Lekha Gupta
Friday, May 17, 2024
Wedbush Reiterates Outperform on Nuvalent, Ma...
Benzinga Newsdesk
Thursday, May 16, 2024
Nuvalent's NVL-655 Receives FDA Breakthrough ...
Benzinga Newsdesk
Thursday, May 09, 2024
Nuvalent Q1 2024 GAAP EPS $(0.69) Misses $(0....
Benzinga Newsdesk
Wednesday, April 17, 2024
Jefferies Initiates Coverage On Nuvalent with...
Benzinga Newsdesk
Monday, April 08, 2024
Nuvalent Presents New Preclinical Data For HE...
Benzinga Newsdesk
Monday, April 01, 2024
Leerink Partners Upgrades Nuvalent to Outperf...
Benzinga Newsdesk
Wednesday, March 06, 2024
JP Morgan Maintains Overweight on Nuvalent, R...
Benzinga Newsdesk
Wednesday, February 28, 2024
Guggenheim Assumes Nuvalent at Buy, Announces...
Benzinga Newsdesk
BMO Capital Maintains Outperform on Nuvalent,...
Benzinga Newsdesk
Tuesday, February 27, 2024
Recap: Nuvalent Q4 Earnings
Benzinga Insights
Nuvalent Q4 EPS $(0.62) Down From $(0.49) YoY...
Benzinga Newsdesk
Nuvalent Secures FDA Breakthrough Therapy Des...
Benzinga Newsdesk
Friday, February 23, 2024
Baird Initiates Coverage On Nuvalent with Out...
Benzinga Newsdesk
Monday, February 12, 2024
Nuvalent Has Initiated Phase 2 Portion Of ALK...
Benzinga Newsdesk
Monday, January 08, 2024
Nuvalent Announced Its "OnTarget 2026" Operat...
Benzinga Newsdesk
Tuesday, November 14, 2023
Recap: Nuvalent Q3 Earnings
Benzinga Insights
Nuvalent Q3 EPS $(0.59) Misses $(0.58) Estima...
Benzinga Newsdesk
Thursday, October 19, 2023
BMO Capital Maintains Outperform on Nuvalent,...
Benzinga Newsdesk
Friday, October 13, 2023
Nuvalent Reports Preliminary Phase 1 Clinical...
Bill Haddad
Friday, October 06, 2023
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Chris Katje
Thursday, October 05, 2023
Nuvalent shares are trading higher after JP M...
Bill Haddad
Where Nuvalent Stands With Analysts
Benzinga Insights
JP Morgan Maintains Overweight on Nuvalent, R...
Benzinga Newsdesk
BMO Capital Maintains Outperform on Nuvalent,...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stifel Reiterates Buy on Nuvalent
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Nuvalent Shares Resume Trade
Benzinga Newsdesk
Nuvalent Announced Preliminary Phase 1 Dose-E...
Benzinga Newsdesk
Nuvalent Shares Halted On Circuit Breaker To ...
Benzinga Newsdesk
Nuvalent Shares Move Higher On Volume
Benzinga Newsdesk
Wednesday, September 27, 2023
Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
Benzinga Insights
Stifel Initiates Coverage On Nuvalent with Bu...
Benzinga Newsdesk
Monday, September 18, 2023
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
Lisa Levin
Nuvalent Will Present Preliminary Dose-escala...
Benzinga Newsdesk
Tuesday, September 05, 2023
Nuvalent Has Initiated The Phase 2 Portion Of...
Benzinga Newsdesk
Thursday, August 10, 2023
Nuvalent Q2 EPS $(0.51) Down From $(0.38) YoY...
Benzinga Newsdesk
Tuesday, August 08, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Benzinga Insights
Expert Ratings for Nuvalent
Benzinga Insights
SVB Leerink Initiates Coverage On Nuvalent wi...
Benzinga Newsdesk
Monday, July 24, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Benzinga Insights
Guggenheim Initiates Coverage On Nuvalent wit...
Benzinga Newsdesk
Thursday, July 20, 2023
Wedbush Reiterates Outperform on Nuvalent, Ma...
Benzinga Newsdesk
Friday, June 23, 2023
JP Morgan Maintains Overweight on Nuvalent, R...
Benzinga Newsdesk
Thursday, May 11, 2023
Nuvalent: Q1 Earnings Insights
Benzinga Insights
Nuvalent Q1 EPS $(0.44) Down From $(0.36) YoY...
Benzinga Newsdesk
Tuesday, April 18, 2023
Nuvalent Presents New Preclinical Data Supporting Intracranial Activity Of NVL-655 At AACR Annual Meeting 2023
Happy Mohamed
Thursday, March 16, 2023
Nuvalent Q4 EPS $(0.49) Misses $(0.43) Estima...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
